The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease. [electronic resource]
- Expert review of cardiovascular therapy Nov 2006
- 801-11 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1744-8344
10.1586/14779072.4.6.801 doi
Biomarkers--metabolism Bone Remodeling Humans Osteoporosis--drug therapy Osteoprotegerin--metabolism RANK Ligand--metabolism Receptor Activator of Nuclear Factor-kappa B--metabolism Vascular Diseases--drug therapy